๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐

13K posts

๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ banner
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐

๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐

@CParkMD

๐ŸŽ—Oncologist|๐ŸงฌCancer Research|President Ky @ASCO|Advisory Dean/Professor @UofL Med School |Faculty @ASCO @NCCN | My Podcast ๐Ÿ‘‰ https://t.co/Of3PVK4RFS

Louisville, KY Katฤฑlฤฑm Temmuz 2019
8.5K Takip Edilen20.7K Takipรงiler
SabitlenmiลŸ Tweet
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Cristiane D Bergerot, PhD, FASCO
10 days to go โณ March 27, 2026 - abstract decisions land in inboxes @ASCO #ASCO26 Who else is feeling the anxiety and counting down?
Cristiane D Bergerot, PhD, FASCO tweet media
English
1
4
25
1.9K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
The Medical Educator Consortium
The Medical Educator Consortium@mecmededucationยท
Redefining GU Oncology: Innovation starts here. ๐Ÿงฌ Join us this week for the MaTOS Genitourinary (GU) Edition in historic Savannah, Georgia! Weโ€™re bringing together global Key Opinion Leaders to dive deep into the latest in molecular diagnosis, epigenomics, and multidisciplinary care. Led by Summit Chairs Petros Grivas, MD, PhD and Chandler H. Park, MD, this is where the latest research meets real-world clinical practice. ๐Ÿ“ JW Marriott Savannah Plant Riverside District ๐Ÿ“… March 19 โ€“ 22, 2026 ๐Ÿ”— Register Now! - matos-gu.com #MaTOS2026 #GUOncology #MedicalSummit #OncologyResearch #SavannahGA #CME #GenitourinaryCancer #MedicalEducation @DrAIravani @rohitjainMD @AJangMD @MosheOrnsteinMD @CParkMD @LuisRaezMD @EddieSantosMD @sonpavde @ChadTangMD @DrKarineTawagi @AbhiTrip87 @drulkav @ZakhariaYousef
The Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet media
Garden City, GA ๐Ÿ‡บ๐Ÿ‡ธ English
0
2
6
305
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Amanda Nizam, MD
Amanda Nizam, MD@AmandaNizamMDยท
Looking forward to this oral presentation tomorrow at #EAU26 discussing our latest work from UNITE! @koshkin85 @DocMattCampbell @Uroweb
Amanda Nizam, MD tweet media
English
1
16
43
3.5K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Cristiane D Bergerot, PhD, FASCO
Cristiane D Bergerot, PhD, FASCO@crisbergerotยท
Honored to be recognized as a 2025 Top Reviewer for both @JCOGO_ASCO and @JCOOP_ASCO. Peer review is a privilege and an essential part of strengthening the science that ultimately improves cancer care. Grateful for the recognition @ASCO
Cristiane D Bergerot, PhD, FASCO tweet mediaCristiane D Bergerot, PhD, FASCO tweet media
English
4
9
51
3.6K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiuยท
Option for dark mode removed from latest X update. To get it back, go to โ€œSettingsโ€ under โ€œDisplay & Brightnessโ€ and select โ€œDarkโ€.
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
23
42
153
30K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Jason Brown
Jason Brown@JasonBrownMDPhDยท
Tanya Jindal@TanyaJindal97

UNITE study data @ASCO #GU26 with @JasonBrownMDPhD In aUC treated with EVP, early ctDNA reduction (โ‰ฅ50% or โ‰ฅ90%) was strongly associated with improved PFS and OS! However, baseline ctDNA levels were not predictive. Early dynamics may guide monitoring @urotoday @Uromigos

English
0
3
20
2.5K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Enrique Grande
Enrique Grande@drenriquegrandeยท
โšก๏ธ Neoadjuvant systemic therapy is reshaping GU oncology: in MIBC, cisplatin-based NAC remains standard (with expanding options like EV+pembro and IO combos, plus emerging ctDNA-guided adjuvant strategies). In RCC, neoadjuvant therapy is still investigationalโ€”early IOยฑTKI trials show feasibility and occasional pCR, but validated pathologic response criteria and surrogacy are still lacking. #BladderCancer #KidneyCancer @JCO_ASCO ascopubs.org/doi/full/10.12โ€ฆ
Enrique Grande tweet mediaEnrique Grande tweet media
English
2
26
76
5.5K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
OncoAlert
OncoAlert@OncoAlertยท
OncoAlert tweet media
English
2
23
40
7.8K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
The Medical Educator Consortium
The Medical Educator Consortium@mecmededucationยท
Don't just exhibitโ€”shape the future of GU Oncology. ๐Ÿ”ฌ๐Ÿ’ผ Is your brand ready to sit at the table with the worldโ€™s leading innovators? Join us for the MaTOS Genitourinary (GU) Edition in Savannah, GA (March 19โ€“22, 2026) for an experience designed for leaders, by leaders. At MaTOS-GU, weโ€™ve eliminated the "noise" of massive trade shows. Instead, we offer Unmatched Access to 50+ Key Opinion Leaders and senior investigators in a high-impact, intimate setting. Why your brand belongs at MaTOS-GU: - Beyond the Booth: Engage in structured Advisory Boards, Expert Exchanges, and VIP Receptions. - Direct Insights: Gain first-hand knowledge of trial design challenges and unmet clinical needs. - Layered Visibility: Secure authentic brand exposure within evidence-based conversations before, during, and after the meeting. - Elite Alignment: Associate your brand with a faculty led by world-renowned experts like Dr. Petros Grivas and Dr. Chandler H. Park. Sponsorship levels are limited to ensure the highest quality of interaction. Secure your place where science meets strategy. ๐Ÿ”—Register today! - matos-gu.com #MaTOS2026 #OncologySponsorship #GUOncology #PharmaNetworking #BiotechEvents @DrAIravani @rohitjainMD @AJangMD @MosheOrnsteinMD @CParkMD @LuisRaezMD @EddieSantosMD @sonpavde @ChadTangMD @DrKarineTawagi @AbhiTrip87 @drulkav @ZakhariaYousef
The Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet mediaThe Medical Educator Consortium tweet media
English
0
4
7
525
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
OncLive.com
OncLive.com@OncLiveยท
๐Ÿงฌ Experts unpack practice-shaping data in RCC, urothelial, & prostate cancer from the 2026 Genitourinary Cancers Symposium โ€” including updates on LITESPARK-022, KEYNOTE-B15, SunRISE-2 & PEACE-3 ๐Ÿ“Š Featuring insights from: @DrChoueiri of @DanaFarber, @CParkMD of @UofL, @AndreaNecchi of @SanRaffaeleMI, @MattGalsky of @TischCancer, and @EnriqueGallar12 of @parctauli @ASCO #GU26 #oncology #medtwitter #kcsm #pcsm Check it out ๐Ÿ‘‰ hubs.li/Q045tN1K0
English
0
3
5
814
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Abby Grier
Abby Grier@abbylgrierยท
Great to be back at ASCO #GU26 for my second year! A whirlwind week of learning and catching up with collaborators and friends. Incredibly grateful for my mentors, who inspire me and made this possible. @JasonBrownMDPhD @PBarataMD @AJangMD @CParkMD @TanyaJindal97 @JeffreyYZhong
Abby Grier tweet mediaAbby Grier tweet mediaAbby Grier tweet media
English
4
4
27
3K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Jeffrey Zhong
Jeffrey Zhong@JeffreyYZhongยท
Had a transformative time at my first @ASCO #GU26! Loved reconnecting with friends and colleagues at such an amazing meeting. Grateful to my mentors, and excited for all the incredible work ahead. @JasonBrownMDPhD @PBarataMD @CParkMD @AJangMD @TanyaJindal97 @abbylgrier
Jeffrey Zhong tweet mediaJeffrey Zhong tweet mediaJeffrey Zhong tweet mediaJeffrey Zhong tweet media
English
3
4
27
1.9K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Chad Tang, MD
Chad Tang, MD@ChadTangMDยท
Excited to review our paper on KIM-1 and ctDNA in oligomet RCC and the K-COMPASS prognostic model published this wk in @EuropeanUrology. Great collaboration between @UTMDAnderson and @DanaFarber. Specifically @VincentWenxinXu and @DrChoueiri Full paper: authors.elsevier.com/a/1mhMr14kpm4Vโ€ฆ
Chad Tang, MD tweet media
English
4
37
94
8.6K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi
Albert Jang, MD
Albert Jang, MD@AJangMDยท
Had a wonderful time catching up with folks and making new friends in sunny San Francisco at @ASCO #GU26! Already waiting for #GU27! @PBarataMD @JasonBrownMDPhD @abbylgrier @TanyaJindal97 @JeffreyYZhong @CParkMD @JZarkaMD @TayoAdeoyeMD @arnabguonc @ZakhariaYousef @Parminder1699
Albert Jang, MD tweet mediaAlbert Jang, MD tweet mediaAlbert Jang, MD tweet mediaAlbert Jang, MD tweet media
English
1
6
29
2K
๐‚๐ก๐š๐ง๐๐ฅ๐ž๐ซ ๐๐š๐ซ๐ค ๐Œ๐ƒ ๐…๐€๐‚๐ retweetledi